The New York Times – Business:
Clinical results of a GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable drugs.
The New York Times – Business:
Clinical results of a GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable drugs.
The New York Times – Business:
China is facing a double whammy: corrosive deflation and tariffs that threaten to block trade. Chinese workers will be the biggest casualties.
The New York Times – Business:
Our Frugal Travel columnist took a budget-stretching, four-day trip to one of the world’s most expensive cities. Would chasing bargains lessen, or enhance, her experience?
The New York Times – Business:
The former Hospital for the Negro Insane of Maryland was once the state’s most crowded psychiatric institution. Pulling off a plan to redevelop it won’t be easy.
The New York Times – Business:
The move would be a major escalation of the Trump administration’s attempts to choke off federal money and support for the leading research university.
The New York Times – Business:
Two reporters spent over a month compiling and analyzing information about the reams of data the U.S. government collects about Americans.
The New York Times – Business:
Jerome H. Powell warned that President Trump’s tariffs could lead to a “challenging scenario” for the central bank.
The New York Times – Business:
Organized labor has taken a leading role in challenging the Trump administration’s downsizing agenda in court. A new service will offer more individualized representation.
The New York Times – Business:
The Trump administration’s plan to add steep fees to packages from China will deal a blow to Temu, Shein and some TikTok Shop sellers, worrying American consumers.
The New York Times – Business:
The Consumer Financial Protection Bureau switched sides and backed a federal lawsuit by banks and business groups seeking to eliminate a fee cap the bureau set last year.